Global Abdominal Aortic Aneurysm Drug Market Insights and Forecast to 2026

Publisher Name :
Date: 13-Jul-2020
No. of pages: 113
Inquire Before Buying

Abdominal Aortic Aneurysm Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Abdominal Aortic Aneurysm Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Abdominal Aortic Aneurysm Drug market is segmented into

- BSN-908

- Canakinumab

- CT-2009

- Ticagrelor

- Others

Segment by Application, the Abdominal Aortic Aneurysm Drug market is segmented into

- Hospital

- Clinic

- Others

Regional and Country-level Analysis

The Abdominal Aortic Aneurysm Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Abdominal Aortic Aneurysm Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Abdominal Aortic Aneurysm Drug Market Share Analysis

Abdominal Aortic Aneurysm Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Abdominal Aortic Aneurysm Drug business, the date to enter into the Abdominal Aortic Aneurysm Drug market, Abdominal Aortic Aneurysm Drug product introduction, recent developments, etc.

The major vendors covered:

- AstraZeneca Plc

- Carolus Therapeutics, Inc.

- Novartis AG

- Vida Therapeutics Inc.

- ...

Global Abdominal Aortic Aneurysm Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Abdominal Aortic Aneurysm Drug Product Introduction
1.2 Market Segments
1.3 Key Abdominal Aortic Aneurysm Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type
1.4.2 BSN-908
1.4.3 Canakinumab
1.4.4 CT-2009
1.4.5 Ticagrelor
1.4.6 Others
1.5 Market by Application
1.5.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Abdominal Aortic Aneurysm Drug Market Size, Estimates and Forecasts
2.1.1 Global Abdominal Aortic Aneurysm Drug Revenue 2015-2026
2.1.2 Global Abdominal Aortic Aneurysm Drug Sales 2015-2026
2.2 Global Abdominal Aortic Aneurysm Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Abdominal Aortic Aneurysm Drug Competitor Landscape by Players
3.1 Abdominal Aortic Aneurysm Drug Sales by Manufacturers
3.1.1 Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020)
3.1.2 Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Abdominal Aortic Aneurysm Drug Revenue by Manufacturers
3.2.1 Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020)
3.2.2 Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Abdominal Aortic Aneurysm Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Drug Revenue in 2019
3.2.5 Global Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Abdominal Aortic Aneurysm Drug Price by Manufacturers
3.4 Abdominal Aortic Aneurysm Drug Manufacturing Base Distribution, Product Types
3.4.1 Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Abdominal Aortic Aneurysm Drug Product Type
3.4.3 Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Abdominal Aortic Aneurysm Drug Market Size by Type (2015-2020)
4.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020)
4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020)
4.1.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Abdominal Aortic Aneurysm Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Type (2021-2026)
4.2.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Abdominal Aortic Aneurysm Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Abdominal Aortic Aneurysm Drug Market Size by Application (2015-2020)
5.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020)
5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2015-2020)
5.1.3 Abdominal Aortic Aneurysm Drug Price by Application (2015-2020)
5.2 Abdominal Aortic Aneurysm Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Abdominal Aortic Aneurysm Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Abdominal Aortic Aneurysm Drug by Country
6.1.1 North America Abdominal Aortic Aneurysm Drug Sales by Country
6.1.2 North America Abdominal Aortic Aneurysm Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
6.3 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Abdominal Aortic Aneurysm Drug by Country
7.1.1 Europe Abdominal Aortic Aneurysm Drug Sales by Country
7.1.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
7.3 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Abdominal Aortic Aneurysm Drug by Region
8.1.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region
8.1.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
8.3 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Abdominal Aortic Aneurysm Drug by Country
9.1.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Country
9.1.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
9.3 Central & South America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Abdominal Aortic Aneurysm Drug by Country
10.1.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country
10.1.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
10.3 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.2 Carolus Therapeutics, Inc.
11.2.1 Carolus Therapeutics, Inc. Corporation Information
11.2.2 Carolus Therapeutics, Inc. Description and Business Overview
11.2.3 Carolus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Products Offered
11.2.5 Carolus Therapeutics, Inc. Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Products Offered
11.3.5 Novartis AG Related Developments
11.4 Vida Therapeutics Inc.
11.4.1 Vida Therapeutics Inc. Corporation Information
11.4.2 Vida Therapeutics Inc. Description and Business Overview
11.4.3 Vida Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Products Offered
11.4.5 Vida Therapeutics Inc. Related Developments
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Abdominal Aortic Aneurysm Drug Market Estimates and Projections by Region
12.1.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Regions 2021-2026
12.2 North America Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.2.1 North America: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.2.2 North America: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.2.3 North America: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.3.2 Europe: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Abdominal Aortic Aneurysm Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Abdominal Aortic Aneurysm Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Abdominal Aortic Aneurysm Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Abdominal Aortic Aneurysm Drug Market Segments
Table 2. Ranking of Global Top Abdominal Aortic Aneurysm Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BSN-908
Table 5. Major Manufacturers of Canakinumab
Table 6. Major Manufacturers of CT-2009
Table 7. Major Manufacturers of Ticagrelor
Table 8. Major Manufacturers of Others
Table 9. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Abdominal Aortic Aneurysm Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Abdominal Aortic Aneurysm Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Abdominal Aortic Aneurysm Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Abdominal Aortic Aneurysm Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2019)
Table 18. Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Abdominal Aortic Aneurysm Drug Price (2015-2020) (USD/Pcs)
Table 21. Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Abdominal Aortic Aneurysm Drug Product Type
Table 23. Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2015-2020)
Table 27. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2015-2020)
Table 29. Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2015-2020)
Table 32. North America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 34. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 38. North America Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 72. AstraZeneca Plc Corporation Information
Table 73. AstraZeneca Plc Description and Major Businesses
Table 74. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AstraZeneca Plc Product
Table 76. AstraZeneca Plc Recent Development
Table 77. Carolus Therapeutics, Inc. Corporation Information
Table 78. Carolus Therapeutics, Inc. Description and Major Businesses
Table 79. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Carolus Therapeutics, Inc. Product
Table 81. Carolus Therapeutics, Inc. Recent Development
Table 82. Novartis AG Corporation Information
Table 83. Novartis AG Description and Major Businesses
Table 84. Novartis AG Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Novartis AG Product
Table 86. Novartis AG Recent Development
Table 87. Vida Therapeutics Inc. Corporation Information
Table 88. Vida Therapeutics Inc. Description and Major Businesses
Table 89. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Vida Therapeutics Inc. Product
Table 91. Vida Therapeutics Inc. Recent Development
Table 92. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Abdominal Aortic Aneurysm Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Abdominal Aortic Aneurysm Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Abdominal Aortic Aneurysm Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Abdominal Aortic Aneurysm Drug Players
Table 110. Abdominal Aortic Aneurysm Drug Customers List
Table 111. Abdominal Aortic Aneurysm Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Abdominal Aortic Aneurysm Drug Product Picture
Figure 2. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BSN-908 Product Picture
Figure 4. Canakinumab Product Picture
Figure 5. CT-2009 Product Picture
Figure 6. Ticagrelor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Abdominal Aortic Aneurysm Drug Report Years Considered
Figure 13. Global Abdominal Aortic Aneurysm Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Abdominal Aortic Aneurysm Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Abdominal Aortic Aneurysm Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 18. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 20. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Abdominal Aortic Aneurysm Drug Revenue in 2019
Figure 22. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2019
Figure 25. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type in 2019
Figure 27. Global Abdominal Aortic Aneurysm Drug Market Share by Price Range (2015-2020)
Figure 28. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2019
Figure 30. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application in 2019
Figure 32. North America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 35. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 41. North America Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 42. Europe Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 45. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 46. Germany Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 57. Europe Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 58. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 62. China Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 85. Asia Pacific Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 86. Latin America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 89. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 97. Latin America Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 110. North America Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs